Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06799351Phase 2/3Recruiting
Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Chemotherapy Induced Peripheral Neuropathy (CIPN)NumbnessParesthesia+1 more
PrincipalinvestigatorStart date: 2025-02-07

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Instituto Universitario de Enfermedades Tropicales y Salud Publica de Canarias - Universidad de La Laguna (IUETSPC-ULL)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Francisco Rodríguez-Esparragón, BSc, PhD

Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

Moderately Similar
3 trials

Shared therapeutic areas:

Chemotherapy Induced Peripheral Neuropathy (CIPN)HypesthesiaParesthesia+1 more

Worked with same sponsors:

Bernardino Clavo, MD, PhDCenters for International Business Education and Research+4 more
Collaborated on 1 trial
Similarity Score44%

Gustavo M Callicó, Prof, PhD

University of Las Palmas de Gran Canaria

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy Induced Peripheral Neuropathy (CIPN)HypesthesiaParesthesia+1 more

Worked with same sponsors:

Bernardino Clavo, MD, PhDCenters for International Business Education and Research+3 more
Similarity Score30%

Himar Fabelo, BSc, PhD

Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy Induced Peripheral Neuropathy (CIPN)HypesthesiaParesthesia+1 more

Worked with same sponsors:

Bernardino Clavo, MD, PhDCenters for International Business Education and Research+3 more
Similarity Score30%

Beraat Alptuğ, Asst. Prof. Dr., PhD in Physical Therapy

Head of the Department of Physiotherapy and Rehabilitation Faculty of Health Sciences European University of Lefke

Related
1 trials

Shared therapeutic areas:

HypesthesiaParesthesia
Similarity Score15%

Nazemin Gilanlıoğulları, Asst. Prof. Dr., PhD in Rehabilitation

Faculty of Health Sciences, Vice Dean, European University of Lefke

Related
1 trials

Shared therapeutic areas:

HypesthesiaParesthesia
Similarity Score15%

Seema Nagpal, MD

Stanford University

Related
1 trials

Shared therapeutic areas:

HypesthesiaTingling
Similarity Score15%

Charles L Loprinzi

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

HypesthesiaTingling
Similarity Score15%

Oliver Dorigo, MD, PhD

Stanford University

Related
2 trials

Shared therapeutic areas:

HypesthesiaTingling
Similarity Score15%

Zhanna Abdrakhmanova, BSc in Physical Therapy

European University of Lefke

Related
1 trials

Shared therapeutic areas:

HypesthesiaParesthesia
Similarity Score15%

Tulio Bertorini

University of Tennessee

Related
1 trials

Shared therapeutic areas:

Paresthesia
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06799351Phase 2/3PrincipalInvestigator

Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

Chemotherapy Induced Peripheral Neuropathy (CIPN)NumbnessParesthesia+1 more
Recruiting

All 1 trials loaded